HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 61.6% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,617 shares of the company’s stock after selling 15,405 shares during the period. Allspring Global Investments Holdings LLC’s holdings in HCA Healthcare were worth $3,208,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Centerpoint Advisors LLC purchased a new stake in HCA Healthcare in the fourth quarter valued at approximately $27,000. Atlantic Edge Private Wealth Management LLC acquired a new position in HCA Healthcare during the 4th quarter worth about $27,000. Bruce G. Allen Investments LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $28,000. Rise Advisors LLC purchased a new position in shares of HCA Healthcare in the first quarter valued at approximately $36,000. Finally, Northwest Investment Counselors LLC purchased a new stake in HCA Healthcare during the 1st quarter worth approximately $36,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Robert W. Baird initiated coverage on HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective on the stock. Barclays upped their target price on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research note on Monday, April 29th. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday. TD Cowen dropped their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Finally, Royal Bank of Canada increased their price objective on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $326.53.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $319.70 on Wednesday. The company has a market cap of $83.73 billion, a PE ratio of 15.99, a P/E/G ratio of 1.49 and a beta of 1.68. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $344.20. The stock has a fifty day moving average price of $326.06 and a 200 day moving average price of $317.80.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same quarter last year, the firm earned $4.93 earnings per share. The firm’s revenue was up 11.2% compared to the same quarter last year. Sell-side analysts forecast that HCA Healthcare, Inc. will post 20.92 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were given a dividend of $0.66 per share. The ex-dividend date was Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.83%. HCA Healthcare’s payout ratio is currently 13.16%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the transaction, the executive vice president now owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The disclosure for this sale can be found here. Insiders have sold a total of 12,397 shares of company stock worth $3,921,929 in the last quarter. Company insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.